Prostate Cancer Symptoms and Treatment Options Guide
Prostate cancer is one of the most common cancers in men, and catching it early can save lives.
Understanding symptoms, testing, and modern treatment choices helps you make clear, confident decisions with your care team.About 1 in 8 men will be diagnosed with prostate cancer during their lifetime, according to the American Cancer Society, and early detection offers the best chance for cure. See current statistics from the American Cancer Society (ACS).
Early symptoms and when to see a urologist
In its earliest stages, prostate cancer often causes few or no warning signs. Still, there are several prostate cancer symptoms not to ignore, including changes in urination, blood in urine or semen, pelvic discomfort, and sexual function changes. For a quick refresher on common signs, review the ACS overview of prostate cancer symptoms.
If you notice persistent urinary changes or sexual function concerns, track what you’re experiencing (onset, frequency, triggers) and talk with your primary care clinician or a urologist. Early conversations can rule out benign causes like BPH or infections—or prompt timely testing if cancer is suspected.
- Difficulty starting or stopping urine
- Weak or interrupted urine flow; frequent nighttime urination
- Blood in urine or semen
- Persistent pain or stiffness in the lower back, hips, or pelvis
- Erectile dysfunction or discomfort during ejaculation
Red flags for more advanced disease include unexplained weight loss, new numbness or weakness in the legs, or new bone pain. If these occur, contact your doctor promptly and review the National Cancer Institute’s primer on prostate cancer basics.
If symptoms persist, schedule a urologist visit. A focused evaluation may include a prostate-specific antigen (PSA) blood test and, in some cases, a digital rectal exam (DRE). Learn more about shared decision-making for screening from the USPSTF and patient-friendly guidance from the Urology Care Foundation.
Making sense of Gleason score and risk groups
When prostate cancer is diagnosed, a pathologist grades how the cells look under a microscope. This is summarized as the Gleason score (now commonly reported as Grade Groups 1–5). Lower numbers generally mean slower-growing cancer; higher numbers indicate more aggressive disease. See the NCI definition of the Gleason score and how it’s used.
Doctors combine your PSA, biopsy results, MRI findings, and stage to classify risk (low, intermediate, or high). Risk grouping influences whether active surveillance is reasonable or if treatment such as surgery, radiation, or systemic therapy is recommended. For a deeper dive into staging and risk, review the ACS guide on prostate cancer staging.
Comparing treatment options
Surgery (radical prostatectomy)
A radical prostatectomy removes the prostate gland and some surrounding tissue. Many centers offer minimally invasive or robot-assisted approaches that can reduce blood loss and shorten hospital stays. The ACS outlines what to expect with surgery for prostate cancer, including recovery timelines and potential side effects.
Why some men choose surgery: it can provide precise staging information (via the removed tissue) and, in certain cases, offers excellent long-term control. Potential side effects include urinary incontinence and erectile dysfunction, which often improve over time with pelvic floor therapy, medications, and sexual rehabilitation.
Radiation therapy (IMRT, SBRT, brachytherapy, proton)
Radiation therapy uses high-energy beams to treat the prostate. Common techniques include IMRT (intensity-modulated radiation therapy), SBRT (stereotactic body radiation therapy), and seed implants (brachytherapy). Explore treatment types and side effects in the NCI’s overview of radiation therapy.
Some centers offer proton therapy for prostate cancer. Current evidence suggests similar cancer control to IMRT, with ongoing studies comparing side effects. Learn more in the NCI primer on proton therapy and this NCI update on proton vs. IMRT side effects.
Active surveillance
Active surveillance means closely monitoring low-risk disease with regular PSA tests, MRI, and periodic biopsies, delaying treatment unless signs of progression appear. Benefits include avoiding immediate side effects of surgery or radiation; potential drawbacks include anxiety between checks and a small risk of missing a window for cure if cancer changes. See ACS’s overview of active surveillance.
Advanced and emerging therapies
For more aggressive, metastatic, or recurrent disease, systemic therapies can help control cancer and improve survival.
Hormone therapy (androgen deprivation, ADT)
ADT lowers testosterone to slow cancer growth. Long-term side effects can include hot flashes, fatigue, sexual changes, weight gain, and loss of muscle and bone density. Review options and risks in the ACS section on hormone therapy, and ask your team about exercise, calcium/vitamin D, and bone-strengthening medicines to protect bone health.
Targeted and radiopharmaceutical therapies
Some tumors respond to targeted agents selected by tumor genetics. Examples include PARP inhibitors (e.g., olaparib, rucaparib) for cancers with DNA-repair defects and PSMA-targeted radioligand therapy for PSMA-positive disease. See NCI summaries on PARP inhibitors in prostate cancer and the FDA approval of PSMA-targeted therapy.
Immunotherapy
Options like sipuleucel‑T and, for select biomarker-defined cases, checkpoint inhibitors can help some men with advanced disease. Explore treatment pathways and eligibility in the NCI’s patient PDQ for prostate cancer treatment.
Ask about clinical trials. Trials provide access to cutting‑edge therapies and help move the field forward. Search actively enrolling studies on ClinicalTrials.gov and the NCI trial finder at cancer.gov.
Managing side effects and recognizing recurrence
Sexual health after treatment
Erectile dysfunction is common after surgery or radiation, particularly early on. Effective options include oral medications, vacuum erection devices, injections, counseling, and—in select cases—penile implants. Explore strategies in the ACS resource on sexual health after prostate cancer.
Incontinence recovery
Managing leakage after prostate surgery may involve pelvic floor (Kegel) exercises, supervised pelvic rehabilitation, medications, or minimally invasive procedures. Helpful overviews are available from the Urology Care Foundation on urinary incontinence in men.
Follow-up and recurrence
After definitive treatment, your team will monitor for signs of recurrence—most often through PSA testing and periodic exams. Know your follow-up plan and PSA goals; the ACS explains typical schedules in its guide to post-treatment follow-up.
Finding specialists and financial support
Choosing a trusted care team matters. You can browse NCI‑Designated Cancer Centers, ask your primary care clinician for referrals, or use the Urology Care Foundation’s directory to find a urologist. A dedicated patient navigator—such as those available through the American Cancer Society—can help with scheduling, education, and support.
To understand coverage, review Medicare’s cancer treatment benefits and call your insurer for plan-specific details. If costs are a concern, explore reputable resources such as CancerCare financial assistance and hospital-based patient assistance programs. Most centers also have social workers who can connect you with transportation, lodging, and copay support.
Key takeaways
- Know the symptoms—don’t ignore persistent changes in urination, sexual function, or pelvic pain.
- Ask how your Gleason score/Grade Group and PSA influence risk and treatment choices.
- Discuss prostatectomy vs. radiation, proton therapy vs. IMRT, and whether active surveillance fits your situation.
- Plan ahead for side‑effect management and stick to a clear follow-up schedule.
- Leverage navigators, second opinions, and clinical trials to personalize care.
Being informed about symptoms, diagnosis, and the full range of therapies—from surveillance to advanced treatments—can help you work with your clinicians to choose the path that best matches your goals and values.